Ardelyx Stock Trading Halted Today; FDA Advisory Committee to Discuss XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis
Go back to Ardelyx Stock Trading Halted Today; FDA Advisory Committee to Discuss XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis| Oppenheimer Rising Dividends Fund, Inc. Class A (NASDAQ: ARDX) | Delayed: 3.80 +0.03 (0.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.77 | 52 Week High | $20.98 | |||
| Open | $3.73 | 52 Week Low | $6.36 | |||
| Day High | $3.92 | P/E | N/A | |||
| Day Low | $3.69 | EPS | $0.00 | |||
| Volume | 4,473,736 | |||||
